The Angiotensin-Melatonin Axis

Accumulating evidence indicates that various biological and neuroendocrine circadian rhythms may be disrupted in cardiovascular and metabolic disorders. These circadian alterations may contribute to the progression of disease. Our studies direct to an important role of angiotensin II and melatonin i...

Full description

Saved in:
Bibliographic Details
Main Authors: Luciana A. Campos, Jose Cipolla-Neto, Fernanda G. Amaral, Lisete C. Michelini, Michael Bader, Ovidiu C. Baltatu
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2013/521783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554393997672448
author Luciana A. Campos
Jose Cipolla-Neto
Fernanda G. Amaral
Lisete C. Michelini
Michael Bader
Ovidiu C. Baltatu
author_facet Luciana A. Campos
Jose Cipolla-Neto
Fernanda G. Amaral
Lisete C. Michelini
Michael Bader
Ovidiu C. Baltatu
author_sort Luciana A. Campos
collection DOAJ
description Accumulating evidence indicates that various biological and neuroendocrine circadian rhythms may be disrupted in cardiovascular and metabolic disorders. These circadian alterations may contribute to the progression of disease. Our studies direct to an important role of angiotensin II and melatonin in the modulation of circadian rhythms. The brain renin-angiotensin system (RAS) may modulate melatonin synthesis, a hormone with well-established roles in regulating circadian rhythms. Angiotensin production in the central nervous system may not only influence hypertension but also appears to affect the circadian rhythm of blood pressure. Drugs acting on RAS have been proven effective in the treatment of cardiovascular and metabolic disorders including hypertension and diabetes mellitus (DM). On the other hand, since melatonin is capable of ameliorating metabolic abnormalities in DM and insulin resistance, the beneficial effects of RAS blockade could be improved through combined RAS blocker and melatonin therapy. Contemporary research is evidencing the existence of specific clock genes forming central and peripheral clocks governing circadian rhythms. Further research on the interaction between these two neurohormones and the clock genes governing circadian clocks may progress our understanding on the pathophysiology of disease with possible impact on chronotherapeutic strategies.
format Article
id doaj-art-dab62b2a8b154acd95ca9b15ef42a9c1
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-dab62b2a8b154acd95ca9b15ef42a9c12025-02-03T05:51:38ZengWileyInternational Journal of Hypertension2090-03842090-03922013-01-01201310.1155/2013/521783521783The Angiotensin-Melatonin AxisLuciana A. Campos0Jose Cipolla-Neto1Fernanda G. Amaral2Lisete C. Michelini3Michael Bader4Ovidiu C. Baltatu5Center of Innovation, Technology and Education—(CITE), Camilo Castelo Branco University (UNICASTELO), São José dos Campos Technology Park, Presidente Dutra Road Km 138, 12247-004 São José dos Campos, SP, BrazilDepartment of Physiology, Institute of Biomedical Sciences, University of São Paulo, 05508-000 São Paulo, SP, BrazilDepartment of Physiology, Institute of Biomedical Sciences, University of São Paulo, 05508-000 São Paulo, SP, BrazilDepartment of Physiology, Institute of Biomedical Sciences, University of São Paulo, 05508-000 São Paulo, SP, BrazilCardiovascular Research, Max Delbruck Center for Molecular Medicine, 13125 Berlin, GermanyCenter of Innovation, Technology and Education—(CITE), Camilo Castelo Branco University (UNICASTELO), São José dos Campos Technology Park, Presidente Dutra Road Km 138, 12247-004 São José dos Campos, SP, BrazilAccumulating evidence indicates that various biological and neuroendocrine circadian rhythms may be disrupted in cardiovascular and metabolic disorders. These circadian alterations may contribute to the progression of disease. Our studies direct to an important role of angiotensin II and melatonin in the modulation of circadian rhythms. The brain renin-angiotensin system (RAS) may modulate melatonin synthesis, a hormone with well-established roles in regulating circadian rhythms. Angiotensin production in the central nervous system may not only influence hypertension but also appears to affect the circadian rhythm of blood pressure. Drugs acting on RAS have been proven effective in the treatment of cardiovascular and metabolic disorders including hypertension and diabetes mellitus (DM). On the other hand, since melatonin is capable of ameliorating metabolic abnormalities in DM and insulin resistance, the beneficial effects of RAS blockade could be improved through combined RAS blocker and melatonin therapy. Contemporary research is evidencing the existence of specific clock genes forming central and peripheral clocks governing circadian rhythms. Further research on the interaction between these two neurohormones and the clock genes governing circadian clocks may progress our understanding on the pathophysiology of disease with possible impact on chronotherapeutic strategies.http://dx.doi.org/10.1155/2013/521783
spellingShingle Luciana A. Campos
Jose Cipolla-Neto
Fernanda G. Amaral
Lisete C. Michelini
Michael Bader
Ovidiu C. Baltatu
The Angiotensin-Melatonin Axis
International Journal of Hypertension
title The Angiotensin-Melatonin Axis
title_full The Angiotensin-Melatonin Axis
title_fullStr The Angiotensin-Melatonin Axis
title_full_unstemmed The Angiotensin-Melatonin Axis
title_short The Angiotensin-Melatonin Axis
title_sort angiotensin melatonin axis
url http://dx.doi.org/10.1155/2013/521783
work_keys_str_mv AT lucianaacampos theangiotensinmelatoninaxis
AT josecipollaneto theangiotensinmelatoninaxis
AT fernandagamaral theangiotensinmelatoninaxis
AT lisetecmichelini theangiotensinmelatoninaxis
AT michaelbader theangiotensinmelatoninaxis
AT ovidiucbaltatu theangiotensinmelatoninaxis
AT lucianaacampos angiotensinmelatoninaxis
AT josecipollaneto angiotensinmelatoninaxis
AT fernandagamaral angiotensinmelatoninaxis
AT lisetecmichelini angiotensinmelatoninaxis
AT michaelbader angiotensinmelatoninaxis
AT ovidiucbaltatu angiotensinmelatoninaxis